Home › Trial NCT00082758
hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
- Trial IDNCT00082758
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorChildren's Oncology Group
- Enrollment39
- Start date2005-08
- ConditionsNeuroblastoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.